$NCRA
NOCERA, INC.

2023 Q3 Form 10-Q Financial Statement

#000168316823005956 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $7.283M $5.327M
YoY Change 429.92% 143.85%
Cost Of Revenue $7.232M $5.290M
YoY Change 429.57% 148.23%
Gross Profit $51.37K $37.24K
YoY Change 484.2% -30.47%
Gross Profit Margin 0.71% 0.7%
Selling, General & Admin $319.8K $368.7K
YoY Change -63.66% -15.71%
% of Gross Profit 622.48% 990.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $28.35K $36.88K
YoY Change 10556.02% 8023.35%
% of Gross Profit 55.18% 99.05%
Operating Expenses $319.8K $368.7K
YoY Change -63.66% -15.71%
Operating Profit -$268.4K -$331.4K
YoY Change -69.19% -13.65%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$4.385K -$880.00
YoY Change -155.52% -144.02%
Pretax Income -$272.8K -$332.3K
YoY Change -68.4% -12.97%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$264.1K -$311.4K
YoY Change -69.49% -18.91%
Net Earnings / Revenue -3.63% -5.85%
Basic Earnings Per Share -$0.03 -$0.03
Diluted Earnings Per Share -$0.03 -$0.03
COMMON SHARES
Basic Shares Outstanding 10.02M shares 9.694M shares
Diluted Shares Outstanding 10.02M shares 9.694M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.281M $1.116M
YoY Change -41.86% -30.24%
Cash & Equivalents $1.281M $1.116M
Short-Term Investments $205.9K
Other Short-Term Assets $207.6K $204.9K
YoY Change 264.65% 1083.2%
Inventory $85.86K $86.28K
Prepaid Expenses
Receivables $243.5K $201.1K
Other Receivables $151.5K $7.920K
Total Short-Term Assets $1.970M $1.616M
YoY Change -60.04% -66.52%
LONG-TERM ASSETS
Property, Plant & Equipment $1.558M $1.626M
YoY Change 70.82% 2377.15%
Goodwill $3.906M $3.906M
YoY Change -10.69% 1076.28%
Intangibles $118.2K $122.3K
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.500K $4.664K
YoY Change
Total Long-Term Assets $5.608M $5.681M
YoY Change 6.11% 1243.28%
TOTAL ASSETS
Total Short-Term Assets $1.970M $1.616M
Total Long-Term Assets $5.608M $5.681M
Total Assets $7.578M $7.297M
YoY Change -25.81% 38.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $0.00
YoY Change -100.0% -100.0%
Accrued Expenses $820.00 $820.00
YoY Change -89.58% -96.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $167.1K $169.4K
YoY Change
Total Short-Term Liabilities $1.438M $1.423M
YoY Change -69.21% 45.29%
LONG-TERM LIABILITIES
Long-Term Debt $337.5K $394.4K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $337.5K $394.4K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.438M $1.423M
Total Long-Term Liabilities $337.5K $394.4K
Total Liabilities $1.775M $1.818M
YoY Change -61.99% 85.55%
SHAREHOLDERS EQUITY
Retained Earnings -$16.31M -$16.05M
YoY Change 36.22% 44.46%
Common Stock $10.02K $9.693K
YoY Change 11.1% -9.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.712M $5.377M
YoY Change
Total Liabilities & Shareholders Equity $7.578M $7.297M
YoY Change -25.81% 38.99%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$264.1K -$311.4K
YoY Change -69.49% -18.91%
Depreciation, Depletion And Amortization $28.35K $36.88K
YoY Change 10556.02% 8023.35%
Cash From Operating Activities -$402.1K -$285.5K
YoY Change 1376.61% 222.33%
INVESTING ACTIVITIES
Capital Expenditures -$2.130K $0.00
YoY Change -99.75%
Acquisitions
YoY Change
Other Investing Activities $0.00 $950.00
YoY Change -100.0%
Cash From Investing Activities $2.130K $950.00
YoY Change -100.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 584.5K -39.89K
YoY Change -89.63% 70.47%
NET CHANGE
Cash From Operating Activities -402.1K -285.5K
Cash From Investing Activities 2.130K 950.0
Cash From Financing Activities 584.5K -39.89K
Net Change In Cash 184.5K -324.5K
YoY Change -61.75% 189.75%
FREE CASH FLOW
Cash From Operating Activities -$402.1K -$285.5K
Capital Expenditures -$2.130K $0.00
Free Cash Flow -$399.9K -$285.5K
YoY Change -149.43% 222.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001756180
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41434
dei Entity Registrant Name
EntityRegistrantName
NOCERA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-1626611
dei Entity Address Address Line1
EntityAddressAddressLine1
3F (Building B), No. 185
dei Entity Address Address Line2
EntityAddressAddressLine2
Sec. 1,Datong Rd
dei Entity Address Address Line3
EntityAddressAddressLine3
Xizhi Dist
dei Entity Address City Or Town
EntityAddressCityOrTown
New Taipei City
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
221
dei Entity Address Country
EntityAddressCountry
TW
dei City Area Code
CityAreaCode
886
dei Local Phone Number
LocalPhoneNumber
910-163-358
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
NCRA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10019295 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1116183 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2906074 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
201069 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
209777 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
86282 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
91781 usd
CY2023Q2 NCRA Advance To Suppliers
AdvanceToSuppliers
1732 usd
CY2022Q4 NCRA Advance To Suppliers
AdvanceToSuppliers
1732 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7923 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27470 usd
CY2023Q2 NCRA Financial Assets At Fair Value Through Profit Or Loss
FinancialAssetsAtFairValueThroughProfitOrLoss
203199 usd
CY2022Q4 NCRA Financial Assets At Fair Value Through Profit Or Loss
FinancialAssetsAtFairValueThroughProfitOrLoss
0 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1616388 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3236834 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22426 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22703 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1625608 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
844613 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
122281 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
130434 usd
CY2023Q2 us-gaap Goodwill
Goodwill
3905735 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3905735 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4664 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 usd
CY2023Q2 us-gaap Assets
Assets
7297102 usd
CY2022Q4 us-gaap Assets
Assets
8140319 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2631 usd
CY2023Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
32290 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
38388 usd
CY2023Q2 NCRA Advance Receipts
AdvanceReceipts
388 usd
CY2022Q4 NCRA Advance Receipts
AdvanceReceipts
42880 usd
CY2023Q2 NCRA Due To Related Parties Current1
DueToRelatedPartiesCurrent1
17295 usd
CY2022Q4 NCRA Due To Related Parties Current1
DueToRelatedPartiesCurrent1
18919 usd
CY2023Q2 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1179768 usd
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1179768 usd
CY2023Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
169434 usd
CY2022Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
214913 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
22312 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
22312 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1818 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1920 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1423305 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1521731 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2023Q2 NCRA Longterm Secured Other Borrowing
LongtermSecuredOtherBorrowing
394404 usd
CY2022Q4 NCRA Longterm Secured Other Borrowing
LongtermSecuredOtherBorrowing
436341 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1817709 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1958072 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9693587 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9693587 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9243587 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9243587 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
9693 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9243 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
80 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
80 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21138123 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20484518 usd
CY2023Q2 NCRA Statutory And Other Reserves
StatutoryAndOtherReserves
191219 usd
CY2022Q4 NCRA Statutory And Other Reserves
StatutoryAndOtherReserves
191219 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16046483 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14747461 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
84000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
103594 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
5376632 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6041193 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
102761 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
141054 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5479393 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6182247 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7297102 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8140319 usd
CY2023Q2 us-gaap Revenues
Revenues
5327181 usd
CY2022Q2 us-gaap Revenues
Revenues
2184613 usd
us-gaap Revenues
Revenues
9165044 usd
us-gaap Revenues
Revenues
5103658 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
5289946 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
2131064 usd
us-gaap Cost Of Revenue
CostOfRevenue
9059153 usd
us-gaap Cost Of Revenue
CostOfRevenue
4994867 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
37235 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
53549 usd
us-gaap Gross Profit
GrossProfit
105891 usd
us-gaap Gross Profit
GrossProfit
108791 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
368667 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
437364 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1428004 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1298317 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
368667 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
437364 usd
us-gaap Operating Expenses
OperatingExpenses
1428004 usd
us-gaap Operating Expenses
OperatingExpenses
1298317 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-331432 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-383815 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1322113 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1189526 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-880 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1999 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12388 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1999 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-332312 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-381816 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1334501 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1187527 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2161 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2170 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-332312 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-383977 usd
us-gaap Profit Loss
ProfitLoss
-1334501 usd
us-gaap Profit Loss
ProfitLoss
-1189697 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-20938 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-35479 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-311374 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-383977 usd
us-gaap Net Income Loss
NetIncomeLoss
-1299022 usd
us-gaap Net Income Loss
NetIncomeLoss
-1189697 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-332312 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-383977 usd
us-gaap Profit Loss
ProfitLoss
-1334501 usd
us-gaap Profit Loss
ProfitLoss
-1189697 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
42882 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
148457 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19594 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19226 usd
CY2023Q2 NCRA Total Comprehensive Loss
TotalComprehensiveLoss
-289430 usd
CY2022Q2 NCRA Total Comprehensive Loss
TotalComprehensiveLoss
-235520 usd
NCRA Total Comprehensive Loss
TotalComprehensiveLoss
-1314907 usd
NCRA Total Comprehensive Loss
TotalComprehensiveLoss
-1170471 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-8533 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-23413 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-280897 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-235520 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1291494 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1170471 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0321
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1129
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1368
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1669
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0321
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1129
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1368
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1669
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9693587 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7138587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9494692 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7128642 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9693587 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7138587 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9494692 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7128642 shares
us-gaap Profit Loss
ProfitLoss
-1334501 usd
us-gaap Profit Loss
ProfitLoss
-1189697 usd
us-gaap Depreciation
Depreciation
81608 usd
us-gaap Depreciation
Depreciation
1241 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8152 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
NCRA Gain On Fair Value Change Of Financial Assets Held For Trading
GainOnFairValueChangeOfFinancialAssetsHeldForTrading
3199 usd
NCRA Gain On Fair Value Change Of Financial Assets Held For Trading
GainOnFairValueChangeOfFinancialAssetsHeldForTrading
-0 usd
NCRA Consultancy Services Settled By Equities
ConsultancyServicesSettledByEquities
521100 usd
NCRA Consultancy Services Settled By Equities
ConsultancyServicesSettledByEquities
503000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
132955 usd
us-gaap Share Based Compensation
ShareBasedCompensation
206476 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4273 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-188761 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1343 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-853902 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
27085 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2054 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-239331 usd
NCRA Increase Decrease In Goodwill
IncreaseDecreaseInGoodwill
-0 usd
NCRA Increase Decrease In Goodwill
IncreaseDecreaseInGoodwill
-0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4865 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-46613 usd
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
0 usd
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
-81062 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-2631 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-31405 usd
NCRA Increase Decrease In Advance Receipt
IncreaseDecreaseInAdvanceReceipt
42492 usd
NCRA Increase Decrease In Advance Receipt
IncreaseDecreaseInAdvanceReceipt
581885 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-9387 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-119920 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-190 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-356181 usd
us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
-0 usd
us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
348107 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-649888 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-641848 usd
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
857870 usd
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
-0 usd
NCRA Purchase Of Financial Assets
PurchaseOfFinancialAssets
200000 usd
NCRA Purchase Of Financial Assets
PurchaseOfFinancialAssets
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1057870 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
81034 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
26845 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-81034 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26845 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1100 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-175220 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1789891 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-843913 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2906074 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2444009 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1116183 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1600096 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4769964 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
503000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
129231 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
103155 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-805720 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4699630 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-148457 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
103322 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-383977 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4270518 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6182247 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
23288 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
103155 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
521100 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1002189 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5827601 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-45696 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29800 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-332312 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5479393 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_z4QRgUH2jsK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_863_zHrEpDKQzACa">Concentrations of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were four customers who represent <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zoQJr5pdaS9g" title="Concentration risk">97</span>% of the Company’s total revenue for the six months ended June 30, 2022. There were five customers who represent <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_z6jmWFgelGAi" title="Concentration risk">99</span>% of the Company’s total revenue for the six months ended June 30, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:</p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zwAcIFARHYxj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zsCpHd1Y1KAg" style="display: none">Schedule of concentrations of credit risk</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, <br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGgGLubRwgV" title="Concentration percentage">50.58</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zLnlupK9unK6" title="Concentration percentage">50.83</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsFoSwQ5A1p8" title="Concentration percentage">16.33</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjZr23AMJ95a" title="Concentration percentage">31.82</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zm4bGrQsSyVe" title="Concentration percentage">11.88</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zG1ABLTp6rm6" title="Concentration percentage">14.73</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Customer D</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zY1mTfxEGQp2" title="Concentration percentage">20.18</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp0_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0QVfgaxFzxf" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNQwIWyhmoGi" title="Concentration percentage">98.96</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRLbYKuPRQd8" title="Concentration percentage">97.38</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
209777 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
145352 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
59254 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1625608 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
844613 usd
CY2023Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
201069 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
209777 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
201069 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
86282 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
91781 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
86282 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
91781 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
7923 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
27470 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7923 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27470 usd
CY2022Q4 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
20000 usd
CY2022Q4 us-gaap Area Of Land
AreaOfLand
229 acre
CY2023Q1 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
857870 usd
us-gaap Depreciation
Depreciation
81608 usd
us-gaap Depreciation
Depreciation
1241 usd
CY2023Q2 us-gaap Depreciation
Depreciation
36880 usd
CY2022Q2 us-gaap Depreciation
Depreciation
454 usd
CY2023Q2 NCRA Financial Assets At Fair Value Through Profit Or Loss Funds
FinancialAssetsAtFairValueThroughProfitOrLossFunds
203199 usd
CY2022Q4 NCRA Financial Assets At Fair Value Through Profit Or Loss Funds
FinancialAssetsAtFairValueThroughProfitOrLossFunds
0 usd
CY2023Q2 NCRA Financial Assets At Fair Value Through Profit Or Loss
FinancialAssetsAtFairValueThroughProfitOrLoss
203199 usd
CY2022Q4 NCRA Financial Assets At Fair Value Through Profit Or Loss
FinancialAssetsAtFairValueThroughProfitOrLoss
0 usd
CY2023Q2 NCRA Financial Assets Measured At Fair Value Through Profit Or Loss Current
FinancialAssetsMeasuredAtFairValueThroughProfitOrLossCurrent
0 usd
CY2022Q4 NCRA Financial Assets Measured At Fair Value Through Profit Or Loss Current
FinancialAssetsMeasuredAtFairValueThroughProfitOrLossCurrent
0 usd
CY2023Q2 NCRA Financial Assets Measured At Fair Value Through Profit Or Loss Non Current
FinancialAssetsMeasuredAtFairValueThroughProfitOrLossNonCurrent
203199 usd
CY2022Q4 NCRA Financial Assets Measured At Fair Value Through Profit Or Loss Non Current
FinancialAssetsMeasuredAtFairValueThroughProfitOrLossNonCurrent
0 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
203199 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
0 usd
NCRA Net Gain Changes In Fair Value Of Financial Assets
NetGainChangesInFairValueOfFinancialAssets
3199 usd
CY2023Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
0 usd
CY2023Q2 us-gaap Goodwill
Goodwill
3905735 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3905735 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23391 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0 usd
CY2023Q2 NCRA Deferred Tax Assets Valuation Allowance Currents
DeferredTaxAssetsValuationAllowanceCurrents
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
135325 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
135325 usd
CY2023Q2 NCRA Finite Lived Intangible Assets Translation Adjustments
FiniteLivedIntangibleAssetsTranslationAdjustments
0 usd
CY2022Q4 NCRA Finite Lived Intangible Assets Translation Adjustments
FiniteLivedIntangibleAssetsTranslationAdjustments
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13044 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4891 usd
CY2023Q2 NCRA Accumulated Impairment Of Intangible Assets Excluding Goodwill
AccumulatedImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022Q4 NCRA Accumulated Impairment Of Intangible Assets Excluding Goodwill
AccumulatedImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
122281 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
130434 usd
CY2023Q2 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
169434 usd
CY2022Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
214913 usd
CY2023Q2 us-gaap Other Loans Payable
OtherLoansPayable
563838 usd
CY2022Q4 us-gaap Other Loans Payable
OtherLoansPayable
651254 usd
CY2022Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
2:3 reverse stock split
CY2022Q4 NCRA Deferred Tax Assets Valuation Allowance Currents
DeferredTaxAssetsValuationAllowanceCurrents
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
32131 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
22976 usd
us-gaap Lease Cost
LeaseCost
32131 usd
us-gaap Lease Cost
LeaseCost
22976 usd
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
822 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
861 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31468 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37527 usd
CY2023Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
32290 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
38388 usd
us-gaap Effective Income Tax Rate Reconciliation Gilti Amount
EffectiveIncomeTaxRateReconciliationGiltiAmount
152829 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
23391 usd
us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.2000 pure
us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.2000 pure
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0005 pure
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0119 pure
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0269 pure
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0919 pure
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.1005 pure
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0365 pure
NCRA Effective Income Tax Rate Reconciliation Utilizationoftaxlosses
EffectiveIncomeTaxRateReconciliationUtilizationoftaxlosses
0 pure
NCRA Effective Income Tax Rate Reconciliation Utilizationoftaxlosses
EffectiveIncomeTaxRateReconciliationUtilizationoftaxlosses
0 pure
us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0 pure
us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.0004 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0720 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0857 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0001 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0018 pure
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95844 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95844 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
NCRA Valuation Allowance Deferred Tax Asset Change In Amount1
ValuationAllowanceDeferredTaxAssetChangeInAmount1
0 usd
CY2022 NCRA Valuation Allowance Deferred Tax Asset Change In Amount1
ValuationAllowanceDeferredTaxAssetChangeInAmount1
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95844 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95844 usd
CY2023Q2 NCRA Due To Related Parties Current1
DueToRelatedPartiesCurrent1
17295 usd
CY2022Q4 NCRA Due To Related Parties Current1
DueToRelatedPartiesCurrent1
18919 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7138587 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9693587 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9693587 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9243587 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9243587 shares
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0116 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0116 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M21D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M21D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4815 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4815 pure
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
709376 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
6638371 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11114097 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y11M26D
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.001
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.50
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-311374 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-383977 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1299022 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1189697 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9693587 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7138587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9494692 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7128642 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9693587 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7138587 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9494692 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7128642 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0321
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1129
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1368
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1669
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.0321
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.1129
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.1368
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.1669

Files In Submission

Name View Source Status
ncra-20230630_def.xml Edgar Link unprocessable
ncra-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001683168-23-005956-index-headers.html Edgar Link pending
0001683168-23-005956-index.html Edgar Link pending
0001683168-23-005956.txt Edgar Link pending
0001683168-23-005956-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ncra-20230630.xsd Edgar Link pending
nocera_ex3101.htm Edgar Link pending
nocera_ex3102.htm Edgar Link pending
nocera_ex3201.htm Edgar Link pending
nocera_ex3202.htm Edgar Link pending
nocera_i10q-063023.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
ncra-20230630_lab.xml Edgar Link unprocessable
ncra-20230630_cal.xml Edgar Link unprocessable
nocera_i10q-063023_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending